CJC-1295 is a synthetic peptide categorized as a growth hormone secretagogue that functions by stimulating the release of endogenous growth hormone through activation of somatotropic receptors. Primarily… Read more
CJC-1295 is a synthetic peptide categorized as a growth hormone secretagogue that functions by stimulating the release of endogenous growth hormone through activation of somatotropic receptors. Primarily investigated for potential therapeutic applications in addressing growth hormone deficiency and supporting conditions requiring muscle mass development, this compound is a focus of ongoing clinical research. In pharmaceutical development and rigorous analytical testing, high-quality reference standards are essential to ensure the accuracy of experimental data. Researchers rely on this collection of CJC-1295 impurities, metabolites, and stable isotope labelled compounds to perform precise impurity profiling, method validation, and quality control. These analytical tools enable laboratories to identify degradation products, confirm structural characterization, and quantify the compound accurately in complex biological matrices, facilitating compliant and reliable pharmaceutical analysis throughout the development lifecycle.